Etiology, clinical profile, and outcomes of crescentic glomerulonephritis in children: a systematic review
- PMID: 39278987
- DOI: 10.1007/s00467-024-06521-3
Etiology, clinical profile, and outcomes of crescentic glomerulonephritis in children: a systematic review
Abstract
Background: Crescentic glomerulonephritis, if not managed promptly, is associated with unsatisfactory outcomes. There are limited studies reporting the outcomes of crescentic glomerulonephritis in children.
Objectives: This systematic review is aimed at synthesizing the data on etiology, clinical profile, and outcomes of crescentic glomerulonephritis in children.
Data sources: We performed a literature search using PubMed, Embase, and Web of Science from inception to January 2024 without language or geographic restrictions.
Study eligibility criteria: Cohort and cross-sectional studies with at least 10 participants reporting etiology, clinical features, and outcomes on crescentic glomerulonephritis in children were considered eligible.
Participants and interventions: Children aged less than 18 years with crescentic glomerulonephritis.
Study appraisal and synthesis methods: We used a tool by Hoy et al. for assessing the quality of studies. We calculated pooled estimates using random effect meta-analyses. Primary outcome was the pooled proportion of patients progressing to kidney failure.
Results: From 1706 records, we included 36 studies (1548 participants) from 16 countries. Etiology was immune-complex glomerulonephritis in 76% (95% CI 67 to 85), pauci-immune in 19% (13 to 25), and anti-GBM disease in 5% (3 to 7) of patients. Gross hematuria, oliguria, edema, and hypertension were observed in 63% (41 to 82), 57% (34 to 79), 79% (65 to 90), and 64% (49 to 77), respectively. In-hospital mortality, reported in 11 studies, was 7% (4 to 11). Progression to kidney failure and chronic kidney disease was reported in 27% (21 to 33) and 50% (29 to 71) of patients, respectively. Risk factors for kidney failure included oliguria, dialysis requirement at onset, estimated GFR, proportion of fibrous crescents, and pauci-immune glomerulonephritis as the underlying etiology.
Limitations: High heterogeneity in pooled estimates of the outcomes.
Conclusions and implications of key findings: Immune-complex glomerulonephritis is the most common etiology in children, with edema, hypertension, gross hematuria, and oliguria being the chief presenting manifestations. Almost one in every four patients with crescentic glomerulonephritis progressed to kidney failure.
Systematic review registration number: PROSPERO registration number CRD42024500515.
Keywords: Chronic kidney disease; Crescents; Kidney failure; Rapidly progressive glomerulonephritis.
© 2024. The Author(s), under exclusive licence to International Pediatric Nephrology Association.
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests.
Similar articles
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
-
Education support services for improving school engagement and academic performance of children and adolescents with a chronic health condition.Cochrane Database Syst Rev. 2023 Feb 8;2(2):CD011538. doi: 10.1002/14651858.CD011538.pub2. Cochrane Database Syst Rev. 2023. PMID: 36752365 Free PMC article.
-
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2. Cochrane Database Syst Rev. 2020. PMID: 33075160 Free PMC article.
-
Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism.Cochrane Database Syst Rev. 2018 Apr 24;4(4):CD008201. doi: 10.1002/14651858.CD008201.pub3. Cochrane Database Syst Rev. 2018. PMID: 29687454 Free PMC article.
Cited by
-
Clinical characteristics, disease flares, infections and their impact on kidney outcomes in pediatric lupus nephritis: A cohort study.Pediatr Nephrol. 2025 Aug;40(8):2529-2538. doi: 10.1007/s00467-025-06666-9. Epub 2025 Feb 1. Pediatr Nephrol. 2025. PMID: 39891679
References
-
- Hénique C, Papista C, Guyonnet L, Lenoir O, Tharaux PL (2014) Update on crescentic glomerulonephritis. Semin Immunopathol 36:479–490 - PubMed
-
- Trimarchi H (2022) Crescents in primary glomerulonephritis: a pattern of injury with dissimilar actors. A pathophysiologic perspective. Pediatr Nephrol 37:1205–1214 - PubMed
-
- Sakthirajan R, Dhanapriya J, Nagarajan M, Dineshkumar T, Balasubramaniyan T, Gopalakrishnan N (2018) Crescentic infection related glomerulonephritis in adult and its outcome. Saudi J Kidney Dis Transpl 29:623–629 - PubMed
-
- Sinha A, Puri K, Hari P, Dinda AK, Bagga A (2013) Etiology and outcome of crescentic glomerulonephritis. Indian Pediatr 50:283–288 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials